Your browser doesn't support javascript.
loading
SPL7013 Gel (VivaGel®) retains potent HIV-1 and HSV-2 inhibitory activity following vaginal administration in humans.
Price, Clare F; Tyssen, David; Sonza, Secondo; Davie, Ashley; Evans, Sonya; Lewis, Gareth R; Xia, Shirley; Spelman, Tim; Hodsman, Peter; Moench, Thomas R; Humberstone, Andrew; Paull, Jeremy R A; Tachedjian, Gilda.
Affiliation
  • Price CF; Starpharma Pty Ltd, Melbourne, Victoria, Australia. clare.price@starpharma.com
PLoS One ; 6(9): e24095, 2011.
Article in En | MEDLINE | ID: mdl-21935377
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polylysine / Herpesvirus 2, Human / Herpesvirus 1, Human / Dendrimers / Gels Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polylysine / Herpesvirus 2, Human / Herpesvirus 1, Human / Dendrimers / Gels Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Document type: Article Affiliation country: Country of publication: